Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography | 20 | 2023 | 5097 | 1.310 |
Why?
|
Heart Ventricles | 16 | 2019 | 3801 | 0.960 |
Why?
|
Marfan Syndrome | 7 | 2020 | 240 | 0.870 |
Why?
|
Heart Defects, Congenital | 19 | 2021 | 4566 | 0.800 |
Why?
|
Atenolol | 7 | 2020 | 100 | 0.800 |
Why?
|
Losartan | 7 | 2020 | 298 | 0.700 |
Why?
|
Norwood Procedures | 6 | 2019 | 182 | 0.590 |
Why?
|
Echocardiography, Doppler | 7 | 2019 | 934 | 0.450 |
Why?
|
Hypoplastic Left Heart Syndrome | 6 | 2018 | 568 | 0.450 |
Why?
|
Ventricular Function, Right | 4 | 2019 | 592 | 0.440 |
Why?
|
Enalapril | 4 | 2019 | 327 | 0.430 |
Why?
|
Heart | 4 | 2023 | 4462 | 0.410 |
Why?
|
Ventricular Septum | 1 | 2011 | 73 | 0.380 |
Why?
|
Pulmonary Atresia | 1 | 2011 | 160 | 0.360 |
Why?
|
Ultrasonography, Prenatal | 7 | 2021 | 1694 | 0.340 |
Why?
|
Cardiology | 2 | 2023 | 1658 | 0.340 |
Why?
|
Fetal Heart | 2 | 2010 | 276 | 0.330 |
Why?
|
alpha-Glucosidases | 1 | 2008 | 44 | 0.330 |
Why?
|
Pregnancy in Diabetics | 1 | 2010 | 179 | 0.320 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2008 | 41 | 0.320 |
Why?
|
Blalock-Taussig Procedure | 3 | 2019 | 62 | 0.310 |
Why?
|
Coronary Vessel Anomalies | 1 | 2011 | 314 | 0.310 |
Why?
|
Aortic Diseases | 3 | 2018 | 741 | 0.280 |
Why?
|
Aorta | 5 | 2018 | 2057 | 0.270 |
Why?
|
Abnormalities, Multiple | 2 | 2011 | 1416 | 0.250 |
Why?
|
Heart Bypass, Right | 2 | 2017 | 74 | 0.250 |
Why?
|
Point-of-Care Systems | 2 | 2023 | 1175 | 0.240 |
Why?
|
Education, Medical | 1 | 2015 | 1717 | 0.230 |
Why?
|
Infant | 25 | 2023 | 35070 | 0.220 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 5 | 2020 | 453 | 0.210 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2021 | 591 | 0.210 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2017 | 1517 | 0.200 |
Why?
|
Pediatrics | 2 | 2017 | 3462 | 0.190 |
Why?
|
Pulmonary Artery | 3 | 2013 | 1911 | 0.190 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2020 | 51 | 0.190 |
Why?
|
Clinical Competence | 1 | 2015 | 4681 | 0.170 |
Why?
|
Fetus | 3 | 2021 | 1879 | 0.170 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2008 | 1263 | 0.170 |
Why?
|
Ventricular Remodeling | 3 | 2019 | 1224 | 0.170 |
Why?
|
Ventricular Pressure | 1 | 2019 | 199 | 0.170 |
Why?
|
Aortic Coarctation | 1 | 2001 | 281 | 0.160 |
Why?
|
Mitral Valve Stenosis | 1 | 2001 | 376 | 0.160 |
Why?
|
Cardiac Surgical Procedures | 4 | 2021 | 3526 | 0.160 |
Why?
|
Infant, Newborn | 16 | 2021 | 25575 | 0.150 |
Why?
|
Aortic Valve Stenosis | 3 | 2007 | 1941 | 0.140 |
Why?
|
Antihypertensive Agents | 4 | 2019 | 2043 | 0.140 |
Why?
|
Arteries | 1 | 2001 | 1118 | 0.130 |
Why?
|
Heart Aneurysm | 1 | 1995 | 120 | 0.120 |
Why?
|
Cerebrovascular Circulation | 2 | 2016 | 2732 | 0.120 |
Why?
|
Prenatal Diagnosis | 1 | 2021 | 1232 | 0.120 |
Why?
|
Data Collection | 1 | 2023 | 3339 | 0.120 |
Why?
|
Situs Inversus | 1 | 1993 | 64 | 0.120 |
Why?
|
Pregnancy Trimester, Second | 2 | 2021 | 732 | 0.110 |
Why?
|
Atrioventricular Node | 1 | 1993 | 182 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2001 | 1155 | 0.110 |
Why?
|
Tricuspid Valve | 2 | 2014 | 400 | 0.110 |
Why?
|
Child | 16 | 2023 | 77478 | 0.110 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 3 | 2020 | 30 | 0.100 |
Why?
|
Aneurysm, False | 1 | 1995 | 276 | 0.100 |
Why?
|
Calcinosis | 1 | 2001 | 1497 | 0.100 |
Why?
|
Child, Preschool | 15 | 2020 | 40955 | 0.100 |
Why?
|
Catheterization | 2 | 2007 | 1468 | 0.100 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5724 | 0.100 |
Why?
|
Reproducibility of Results | 5 | 2023 | 19862 | 0.100 |
Why?
|
Tachycardia | 1 | 1993 | 620 | 0.100 |
Why?
|
Heart Septal Defects | 1 | 2011 | 192 | 0.090 |
Why?
|
Fetal Development | 1 | 2016 | 767 | 0.090 |
Why?
|
Postoperative Care | 1 | 2016 | 1484 | 0.090 |
Why?
|
Treatment Outcome | 14 | 2021 | 62966 | 0.090 |
Why?
|
Humans | 46 | 2023 | 742088 | 0.090 |
Why?
|
Aortic Aneurysm | 1 | 2014 | 643 | 0.090 |
Why?
|
Ventricular Function | 1 | 2011 | 416 | 0.090 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 1473 | 0.090 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2014 | 578 | 0.080 |
Why?
|
Palliative Care | 3 | 2019 | 3478 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1239 | 0.080 |
Why?
|
Fontan Procedure | 1 | 2014 | 768 | 0.080 |
Why?
|
Female | 30 | 2021 | 379592 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3656 | 0.070 |
Why?
|
Stroke Volume | 3 | 2015 | 4983 | 0.070 |
Why?
|
Renin-Angiotensin System | 1 | 2011 | 759 | 0.070 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2013 | 685 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2021 | 15244 | 0.070 |
Why?
|
Male | 25 | 2021 | 349538 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2014 | 1573 | 0.070 |
Why?
|
Image Enhancement | 1 | 2016 | 2921 | 0.070 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39004 | 0.070 |
Why?
|
Coronary Circulation | 1 | 2011 | 1572 | 0.060 |
Why?
|
Fetal Therapies | 1 | 2006 | 100 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2020 | 77098 | 0.060 |
Why?
|
Myocardium | 2 | 2021 | 4775 | 0.060 |
Why?
|
Maternal Health Services | 1 | 2010 | 452 | 0.060 |
Why?
|
Pregnancy | 7 | 2021 | 29087 | 0.060 |
Why?
|
Diastole | 2 | 2019 | 791 | 0.060 |
Why?
|
Pulsatile Flow | 2 | 2016 | 332 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 2271 | 0.060 |
Why?
|
Adolescent | 12 | 2020 | 85649 | 0.060 |
Why?
|
Middle Cerebral Artery | 2 | 2016 | 264 | 0.060 |
Why?
|
Boston | 2 | 2016 | 9305 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2885 | 0.050 |
Why?
|
Double-Blind Method | 5 | 2019 | 12017 | 0.050 |
Why?
|
Young Adult | 7 | 2021 | 56350 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 12071 | 0.050 |
Why?
|
Radiography, Thoracic | 1 | 2008 | 1265 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 53187 | 0.050 |
Why?
|
Mitral Valve Insufficiency | 1 | 2011 | 1415 | 0.050 |
Why?
|
North America | 2 | 2017 | 1249 | 0.050 |
Why?
|
Quality Improvement | 1 | 2016 | 3738 | 0.050 |
Why?
|
Child Development | 1 | 2013 | 2222 | 0.050 |
Why?
|
Adult | 14 | 2023 | 213712 | 0.050 |
Why?
|
Systole | 2 | 2014 | 956 | 0.050 |
Why?
|
Linear Models | 3 | 2018 | 5948 | 0.050 |
Why?
|
Baltimore | 1 | 2001 | 231 | 0.050 |
Why?
|
Infant, Low Birth Weight | 1 | 2005 | 850 | 0.050 |
Why?
|
Catheter Ablation | 1 | 1993 | 2746 | 0.040 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2001 | 364 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2011 | 4567 | 0.040 |
Why?
|
Gestational Age | 3 | 2016 | 3490 | 0.040 |
Why?
|
Electrocardiography | 2 | 2008 | 6440 | 0.040 |
Why?
|
Fatal Outcome | 2 | 2001 | 1849 | 0.040 |
Why?
|
Odds Ratio | 1 | 2011 | 9846 | 0.040 |
Why?
|
Advisory Committees | 1 | 2023 | 773 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2008 | 6608 | 0.040 |
Why?
|
Patient Selection | 2 | 2012 | 4214 | 0.040 |
Why?
|
Organ Size | 2 | 2014 | 2253 | 0.040 |
Why?
|
American Heart Association | 1 | 2023 | 1055 | 0.040 |
Why?
|
Thorax | 1 | 2021 | 547 | 0.040 |
Why?
|
Biometry | 1 | 2021 | 558 | 0.040 |
Why?
|
Risk Factors | 5 | 2021 | 72145 | 0.040 |
Why?
|
Sodium Channels | 1 | 1999 | 349 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2005 | 1255 | 0.040 |
Why?
|
Quality of Life | 1 | 2018 | 12730 | 0.040 |
Why?
|
Dilatation | 1 | 2018 | 286 | 0.040 |
Why?
|
Missouri | 1 | 2016 | 116 | 0.040 |
Why?
|
Vena Cava, Superior | 1 | 1997 | 194 | 0.040 |
Why?
|
Aldosterone | 2 | 2011 | 876 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 269 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2001 | 903 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12773 | 0.030 |
Why?
|
Medical Records | 1 | 2001 | 1413 | 0.030 |
Why?
|
Long QT Syndrome | 1 | 1999 | 453 | 0.030 |
Why?
|
Electronic Mail | 1 | 2017 | 213 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1999 | 1526 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14720 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2005 | 3099 | 0.030 |
Why?
|
Bundle of His | 1 | 1993 | 88 | 0.030 |
Why?
|
United States | 4 | 2023 | 69693 | 0.030 |
Why?
|
Reoperation | 2 | 2012 | 4200 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2018 | 968 | 0.030 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 1993 | 117 | 0.030 |
Why?
|
Ebstein Anomaly | 1 | 1993 | 97 | 0.030 |
Why?
|
Tachycardia, Ventricular | 1 | 2001 | 1272 | 0.030 |
Why?
|
Genotype | 2 | 2020 | 12946 | 0.030 |
Why?
|
Heart Failure | 2 | 2017 | 10856 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 40054 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12344 | 0.020 |
Why?
|
Risk Assessment | 3 | 2018 | 23320 | 0.020 |
Why?
|
Angiotensins | 1 | 2011 | 151 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2593 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3528 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15530 | 0.020 |
Why?
|
Aortic Valve Insufficiency | 1 | 2014 | 577 | 0.020 |
Why?
|
Mutation, Missense | 1 | 1999 | 2556 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2013 | 936 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 1995 | 933 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4929 | 0.020 |
Why?
|
Ultrasonography | 1 | 2022 | 5978 | 0.020 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2011 | 365 | 0.020 |
Why?
|
Renin | 1 | 2011 | 642 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2011 | 683 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12242 | 0.020 |
Why?
|
Vasodilation | 1 | 2013 | 944 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2012 | 985 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2924 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2014 | 13921 | 0.020 |
Why?
|
Survival Analysis | 1 | 2001 | 10248 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13403 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29010 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 1995 | 1385 | 0.020 |
Why?
|
Syndrome | 1 | 1993 | 3248 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6534 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3510 | 0.020 |
Why?
|
Abortion, Therapeutic | 1 | 2006 | 35 | 0.020 |
Why?
|
Hemodynamics | 2 | 2007 | 4197 | 0.020 |
Why?
|
DNA | 1 | 2020 | 7289 | 0.020 |
Why?
|
Growth Disorders | 1 | 2011 | 643 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5238 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3527 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2015 | 1831 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6891 | 0.010 |
Why?
|
Fetal Death | 1 | 2006 | 447 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 2005 | 520 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15056 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20928 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2167 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8297 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4211 | 0.010 |
Why?
|
Recurrence | 1 | 1993 | 8333 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2566 | 0.010 |
Why?
|
Oxygen | 1 | 2013 | 4169 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7901 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4328 | 0.010 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 546 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2012 | 3119 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6294 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2012 | 5310 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4455 | 0.010 |
Why?
|
Fever | 1 | 2005 | 1612 | 0.010 |
Why?
|
Middle Aged | 2 | 2010 | 213127 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2007 | 2795 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1999 | 1245 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18355 | 0.010 |
Why?
|
Infant, Premature | 1 | 2005 | 2041 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 1999 | 1792 | 0.010 |
Why?
|
Decision Making | 1 | 2006 | 3869 | 0.010 |
Why?
|
Pedigree | 1 | 1999 | 4646 | 0.010 |
Why?
|
Heart Atria | 1 | 1997 | 1348 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4742 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2005 | 12958 | 0.010 |
Why?
|
Models, Molecular | 1 | 1999 | 5454 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 40450 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1997 | 2267 | 0.000 |
Why?
|
Brain | 1 | 2013 | 26343 | 0.000 |
Why?
|
Genetic Variation | 1 | 1999 | 6540 | 0.000 |
Why?
|
Aged | 1 | 1997 | 162944 | 0.000 |
Why?
|